Comparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycaemic control without hypoglycaemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study, a 48‐week, multi‐centre, randomized, controlled trial-Reference-Cited by-同舟云学术

Comparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycaemic control without hypoglycaemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study, a 48‐week, multi‐centre, randomized, controlled trial

Published:2019-04 Issue:4 Volume:21 Page:939-948
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Gu Tianwei¹^ORCID,Ma Jianhua²,Zhang Qiu³,Zhu Liangying¹,Zhang Hong⁴,Xu Lan⁵,Cheng Jinluo⁶,Shi Bimin⁷,Li Dongmei⁸,Shao Jiaqing⁹,Sun Zilin¹⁰,Zhong Shao¹¹,Bi Yan¹^ORCID,Zhu Dalong¹

Affiliation:

1. Department of EndocrinologyDrum Tower Hospital Affiliated to Nanjing University Medical School Nanjing China

2. Department of EndocrinologyNanjing First Hospital, Nanjing Medical University Nanjing China

3. Department of EndocrinologyThe First Affiliated Hospital of Anhui Medical University Hefei China

4. Department of EndocrinologyHuai'an First People's Hospital Huai'an China

5. Department of EndocrinologyWuxi First People's Hospital Wuxi China

6. Department of EndocrinologyChangzhou Second People's Hospital affiliated to Nanjing Medical University Changzhou China

7. Department of EndocrinologyThe First Affiliated Hospital of Soochow University Suzhou China

8. Department of EndocrinologyNanjing Pukou District Central Hospital Nanjing China

9. Department of Endocrinology, Jinling HospitalMedical School of Nanjing University Nanjing China

10. Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of MedicineSoutheast University Nanjing China

11. Department of EndocrinologyKunshan First People's Hospital Suzhou China

Funder

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13605

Reference31 articles.

1. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018

2. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

3. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes

4. Do sulphonylureas still have a place in clinical practice?

5. Glimepiride: evidence-based facts, trends, and observations

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-06

2. The “Old” Oral Antidiabetics;The Diabetes Textbook;2023

3. Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials;BMJ;2022-06-28

4. Harmful versus beneficial effects of using short-term combined oral antidiabetic therapy: ‎An open label comparative clinical trial ‎;Clinical Diabetology;2021-05-20

5. Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus;Journal of Diabetes Investigation;2020-03-27